| Active cyclin B1–Cdk1 first appears on centrosomes in prophase M Jackman, C Lindon, EA Nigg, J Pines Nature cell biology 5 (2), 143-148, 2003 | 753 | 2003 |
| Ordered proteolysis in anaphase inactivates Plk1 to contribute to proper mitotic exit in human cells C Lindon, J Pines The Journal of cell biology 164 (2), 233-241, 2004 | 445 | 2004 |
| Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion JW Connell, C Lindon, JP Luzio, E Reid Traffic 10 (1), 42-56, 2009 | 272 | 2009 |
| Early mitotic degradation of Nek2A depends on Cdc20-independent interaction with the APC/C MJ Hayes, Y Kimata, SL Wattam, C Lindon, G Mao, H Yamano, AM Fry Nature cell biology 8 (6), 607-614, 2006 | 200 | 2006 |
| Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin TB Nguyen, K Manova, P Capodieci, C Lindon, S Bottega, XY Wang, ... Journal of Biological Chemistry 277 (44), 41960-41969, 2002 | 192 | 2002 |
| APC/CCdh1 targets aurora kinase to control reorganization of the mitotic spindle at anaphase S Floyd, J Pines, C Lindon Current Biology 18 (21), 1649-1658, 2008 | 162 | 2008 |
| Cell cycle–regulated expression of the muscle determination factor Myf5 in proliferating myoblasts C Lindon, D Montarras, C Pinset The Journal of cell biology 140 (1), 111-118, 1998 | 144 | 1998 |
| The Aurora-A/TPX2 complex: a novel oncogenic holoenzyme? IA Asteriti, WM Rensen, C Lindon, P Lavia, G Guarguaglini Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1806 (2), 230-239, 2010 | 142 | 2010 |
| Proteolysis: anytime, any place, anywhere? J Pines, C Lindon Nature cell biology 7 (8), 731-735, 2005 | 113 | 2005 |
| Control of Aurora-A stability through interaction with TPX2 M Giubettini, IA Asteriti, J Scrofani, M De Luca, C Lindon, P Lavia, ... Journal of cell science 124 (1), 113-122, 2011 | 103 | 2011 |
| A quantitative protocol for dynamic measurements of protein interactions by Förster resonance energy transfer-sensitized fluorescence emission AD Elder, A Domin, GS Kaminski Schierle, C Lindon, J Pines, A Esposito, ... Journal of The Royal Society Interface 6 (suppl_1), S59-S81, 2009 | 100 | 2009 |
| Cultured myf5 null and myoD null muscle precursor cells display distinct growth defects D Montarras, C Lindon, C Pinset, P Domeyne Biology of the Cell 92 (8‐9), 565-572, 2000 | 97 | 2000 |
| Overexpressed BCL6 (LAZ3) oncoprotein triggers apoptosis, delays S phase progression and associates with replication foci O Albagli, D Lantoine, S Quief, F Quignon, C Englert, JP Kerckaert, ... Oncogene 18 (36), 5063-5075, 1999 | 94 | 1999 |
| Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1 BCM Van De Weerdt, MATM Van Vugt, C Lindon, JJW Kauw, ... Molecular and cellular biology 25 (5), 2031-2044, 2005 | 80 | 2005 |
| Efficient APC/C substrate degradation in cells undergoing mitotic exit depends on K11 ubiquitin linkages M Min, TET Mevissen, M De Luca, D Komander, C Lindon Molecular biology of the cell 26 (24), 4325-4332, 2015 | 74 | 2015 |
| Ubiquitin-mediated degradation of aurora kinases C Lindon, R Grant, M Min Frontiers in Oncology 5, 307, 2016 | 66 | 2016 |
| Ubiquitination site preferences in anaphase promoting complex/cyclosome (APC/C) substrates M Min, U Mayor, C Lindon Open biology 3 (9), 130097, 2013 | 55 | 2013 |
| Activating transcription factor-1 is a specific antagonist of the cyclic adenosine 3'. 5'-monophosphate (cAMP) response element-binding protein-1-mediated response to cAMP. MJ Ellis, AC Lindon, KJ Flint, NC Jones, S Goodbourn Molecular Endocrinology 9 (2), 255-265, 1995 | 49 | 1995 |
| Using in vivo biotinylated ubiquitin to describe a mitotic exit ubiquitome from human cells M Min, U Mayor, G Dittmar, C Lindon Molecular & Cellular Proteomics 13 (9), 2411-2425, 2014 | 44 | 2014 |
| Control of mitotic exit and cytokinesis by the APC/C C Lindon Biochemical Society Transactions 36 (3), 405-410, 2008 | 42 | 2008 |
